ϩ (Kv) currents may underlie arrhythmias after myocardial infarction (MI). We investigated the role of ␤-adrenergic signaling and the calcineurin/NFAT pathway in mediating the reductions in Kv currents observed after MI in mouse ventricular myocytes. Kv currents were produced by the summation of 3 distinct currents: I to , I Kslow1 , and I Kslow2 . At 48 hours after MI, we found a 4-fold increase in NFAT activity, which coincided with a decrease in the amplitudes of I to , I Kslow1 , and I Kslow2 . Consistent with this, mRNA and protein levels of Kv1.5, 2.1, 4.2, and 4.3, which underlie I Kslow1 , I Kslow2 , and I to , were decreased after MI. Administration of the ␤-blocker metoprolol prevented the activation of NFAT and the reductions in I to , I Kslow1 , and I Kslow2 after MI. Cyclosporine, an inhibitor of calcineurin, also prevented the reductions in these currents after MI. Importantly, Kv currents did not change after MI in ventricular myocytes from NFATc3 knockout mice. Conversely, chronic ␤-adrenergic stimulation or expression of an activated NFATc3 decreased Kv currents to a similar extent as MI. Taken together, these data indicate that NFATc3 plays an essential role in the signaling pathway leading to reduced I to , I Kslow1 , and I Kslow2 after MI. We propose that increased ␤-adrenergic signaling after MI activates calcineurin and NFATc3, which decreases I to , I Kslow1 , and I Kslow2 via a reduction in
A rrhythmias are a major cause of death after myocardial infarction (MI). Mounting evidence suggests that modification of the ventricular action potential (AP) underlies the increased probability of developing lethal arrhythmias after MI. [1] [2] [3] [4] [5] Changes in the AP, including reductions in the rate of depolarization, peak depolarization, 5 and an increase in the AP duration 3 have been reported in regions proximal to and removed from the infarct zone. These changes in the AP are produced by reductions in the magnitudes of Na ϩ 6 and Kv 1,2 currents as well as changes in Ca 2ϩ signaling proteins 7 of ventricular myocytes. Some of these changes can occur rapidly; decreased Kv currents have been reported 3 days after MI. 1, 2 However, the signaling mechanisms underlying these profound electrical changes in the heart are unclear.
Recent studies have suggested a role for increased ␤-adrenergic receptor (␤AR) signaling in the development of the hypertrophic phenotype post-MI, including changes in Kv currents. 8 -10 Accordingly, catecholamine levels in the heart, as well as protein kinase A (PKA) activity in ventricular myocytes, have been found to increase after MI. 9, 10 Augmentation of PKA activity can elicit profound changes in myocardial Ca 2ϩ signaling, including increased Ca 2ϩ currents and sarcoplasmic reticulum (SR) Ca 2ϩ release. 11 Furthermore, chronic activation of PKA causes cardiac hypertrophy and increases the probability of arrhythmogenesis and sudden death. 12 The Ca 2ϩ -activated phosphatase calcineurin has been hypothesized to play a pivotal role in translating altered Ca 2ϩ signaling into changes in the transcription of genes linked to the development of hypertrophy and heart failure. 13 On activation, calcineurin dephosphorylates NFAT, allowing translocation into the nucleus, whereupon it modulates the transcription of multiple genes. Expression of an activated form of NFATc4 is sufficient to induce robust hypertrophy in transgenic mice. 13 However, NFATc3-null, but not NFATc4-null, mice exhibit decreased cardiac hypertrophy in response to calcineurin activation. 14 These findings suggest that while NFATc4 can induce hypertrophy, it is NFATc3 that plays an essential role in the pathway leading to cardiac hypertrophy after calcineurin activation. A recent study found that calcineurin 15 and NFATc3 16 are activated after MI and that inhibition of calcineurin prevented activation of this transcription factor and decreased cardiac hypertrophy post-MI. At present, however, it is unclear if calcineurin/NFATc3 signaling is involved in the electrical remodeling of the heart after MI.
In this study, we examined the role of ␤AR stimulation, calcineurin, and NFATc3 in mediating reductions in Kv currents after MI. Our data suggest that increased ␤-adrenergic signaling activates NFAT after MI. We propose that activation of NFATc3 decreases Kv currents via changes in gene expression. These findings suggest that ␤ARs, calcineurin, and NFATc3 play a crucial role in the pathway leading to reduced Kv currents post-MI.
Methods

Generation of Myocardial Infarcts
Infarcts were generated as previously described 17 in accordance to the guidelines of the Institutional Animal Care and Use Committee. NFATc3 knockout and NFAT reporter mice were kindly provided by Drs Laurie Glimcher (Harvard University, Cambridge, Mass) and Mercedes Rincó n, (University of Vermont, Burlington), respectively.
Isolation, Short-Term Culture, and Adenoviral Infection of Adult Mouse Ventricular Myocytes
Ventricular myocytes from adult mice were isolated from regions remote to the MI (ie, right ventricle, noninfarcted section of the left ventricle and septum) 48 hours post-MI. For control experiments, cells were dissociated from regions of the heart similar to those used from infarcted hearts. Adenoviral infection and short-term culture of adult ventricular myocytes were performed as described elsewhere. 18 
Electrophysiology and Confocal Microscopy
Administration of CsA, FK506, and Metoprolol
Metoprolol (Ϸ350 mg/kg per day) was administered via drinking water. 19 CsA (25 mg/kg per day) and FK506 (3 mg/kg twice per day) were administered intraperitoneally.
Real-Time Reverse-Transcription Polymerase Chain Reaction
Reverse-transcription (RT) was performed using the Superscript First-strand Synthesis system (Invitrogen). Real-time polymerase chain reaction (PCR) was performed with the TaqMan 5Ј nuclease assay and TaqMan Onestep PCR Mastermix.
Western Blots
Protein (50 g) was loaded on a 4% to 15% Tris-HCl polyacrylamide gel and transferred to a polyvinylidene difluoride membrane. Blots were incubated with primary antibodies specific to Kv1.5, 2.1, 4.2, or 4.3, and then with horseradish peroxidase-conjugated secondary antibodies. Kv channel protein was quantified by densitometry.
Luciferase Assay
Luciferase activity was quantified using a commercially available kit (Promega).
Statistics
Data are presented as meanϮSEM. Group comparisons were made using Student t test or ANOVA, which, if necessary, were followed-up by a Tukey test.
An expanded Methods section can be found in the online data supplement available at http://circres.ahajournals.org. Reductions in I to , I Kslow1 , and I Kslow2 After MI One mechanism by which APD could increase after MI is by a decrease in the Kv currents responsible for the repolarization of ventricular cells. Thus, we examined Kv currents in MI (nϭ26) and control (nϭ28) ventricular myocytes ( Figure  2 ). Kv currents were evoked by 1.2-second depolarizing pulses from Ϫ90 mV to potentials ranging from Ϫ60 to ϩ40 mV. The Kv currents evoked by this protocol activated rapidly and then decayed with time ( Figure 2A ). The decaying phase of the Kv currents recorded during depolarization to ϩ40 mV could be fit with the sum of 2 exponential functions. 21 At ϩ40 mV, Kv currents from control cells had a fast ( fast ) and slow ( slow ) time constant of inactivation of 57.2Ϯ9.8 ms and 531.9Ϯ33.8 ms, respectively. MI cells depolarized to the same potential produced Kv currents with similar fast (46.2Ϯ3.4 ms) and slow (616.6Ϯ58.3 ms) (PϾ0.05). However, we found that the amplitudes of the transient (I tran ; defined as the difference between the peak and sustained current measured at the end of the pulse) and sustained (I sust ; defined as the sustained current measured at the end of the pulse) components of Kv (I K ) currents were smaller in MI than in control cells at most potentials examined (Figure 2A through 2C It is important to note that we found no significant differences in the voltage dependencies of conductance and steady-state inactivation of I tran and I sust in control and MI cells (PϾ0.05; data not shown). The voltage at which 50% of I tran and I sust were inactivated was similar in MI (I tran ϭϪ36.7Ϯ1.4 mV; I sust ϭϪ52.5Ϯ2.5 mV, nϭ12) and control cells (I tran ϭ Ϫ38.2Ϯ2.4 mV; I sust ϭϪ49.6Ϯ3.5 mV, nϭ16) (PϾ0.05). Furthermore, I tran and I sust reached 50% of their maximal conductance at a similar voltage in MI (I to ϭ9.7Ϯ4.2 mV; I sust ϭϪ34.0Ϯ3.6 mV) and control (I to ϭ4.5Ϯ1.8 mV; I sust ϭϪ34.9Ϯ3.7 mV) cells (PϾ0.05). Taken together, these data suggest that a reduction in the amplitudes of I tran and I sust contribute to AP prolongation in mouse ventricular myocytes post-MI. The reductions in I tran and I sust were not results of changes in the voltage-dependencies of activation or inactivation of these currents post-MI.
Results
Changes in AP Duration
The next series of experiments investigated the effects of MI on the currents that underlie I tran and I sust in mouse ventricular myocytes ( Figure 2A ). Three kinetically and pharmacologically distinct currents are thought to contribute to I tran and I sust . 22, 23 I tran is produced by the rapidly inactivating transient outward current (I to ), whereas a noninactivating current (I Kslow2 ) contributes to I sust . A slowly inactivating current (I Kslow1 ) contributes to I tran and I sust . Pharmacological tools were used to separate these currents. To isolate I Kslow1 , Kv currents were measured before and after the application of 50 mol/L 4-aminopyridine (4-AP), which blocks this current, but has no effect on I to or I Kslow2 . 22 Subtraction of the currents recorded in the presence of 50 mol/L 4-AP from the predrug traces results in the 4-AP-sensitive current or I Kslow1 . To obtain I Kslow2 , currents recorded during superfusion of a solution containing 50 mol/L 4-AP and 25 mmol/L tetraethylammonium chloride (TEA), which blocks I Kslow2 , but has little effect on I to , 22 were subtracted from currents recorded in the presence of 4-AP. The TEA-sensitive current represents I Kslow2 . The remaining current recorded in the presence of 4-AP and TEA corresponds to I to (defined here as the difference between the peak and sustained current measured at the end of the 1.2-second pulse). I tran , I sust , I to , I Kslow1 , and I Kslow2 were recorded from the same cells.
In agreement with the data shown in Figure 2B and 2C, I to , I Kslow1 , and I Kslow2 were significantly smaller after MI than in control cells ( Figure 2D and 2F) . At ϩ40 mV, the amplitudes of I to and I Kslow1 were nearly 69% and 65% smaller after MI than in control cells, respectively. I Kslow2 decreased by Ϸ30% 48 hours post-MI. These data suggest that the decrease in I tran observed in MI resulted from equivalent reductions in the magnitude of I to and I Kslow1 . The decrease in I sust was produced by reductions in I Kslow1 and I Kslow2 .
We examined the molecular mechanisms underlying the reductions in I to , I Kslow1 , and I Kslow2 observed post-MI. In the mouse ventricle, I to is produced by a heterotetramer formed by Kv4.2 and Kv4.3 subunits. 24 Kv1.5 and Kv2.1, in turn, underlie I Kslow1 25 and I Kslow2 . 26 Thus, we used real-time PCR to examine the mRNA levels of Kv1.5, Kv2.1, Kv4.2, and Kv4.3 in control and MI hearts ( Figure 2G ). Our data indicate that mRNA levels for Kv1.5, Kv2.1, Kv4.2, and Kv4.3 were Ϸ47%, 30%, 62%, and 41% lower (PϽ0.05) in MI (nϭ9 hearts) than in control (nϭ9 hearts) ventricles, respectively. Additional experiments using actinomycin D (see online data supplement) demonstrated that this decrease in mRNA did not result from an increase in the degradation rate of Kv1.5, Kv2.1, Kv4.2, or Kv4.3 transcripts in ventricular myocytes after MI. Consistent with our electrophysiological and mRNA data, Western blot analysis of fractionated ventricular membrane proteins (50 g total protein) revealed that Kv1.5, Kv2.1, Kv4.2, and Kv4.3 protein decreased by 45%Ϯ10%, 48%Ϯ10%, 61%Ϯ13%, and 55%Ϯ5%, respectively, after MI (nϭ9 hearts, PϽ0.05) ( Figure 2H ). These data suggest that the decreases in I to , I Kslow1 , and I Kslow2 observed post-MI result from decreases in the expression of Kv1.5, Kv2.1, Kv4.2, and Kv4.3 mRNA and protein.
Administration of the ␤-Blocker Metoprolol Prevents Reductions in I to and I sust After MI
Administration of ␤-blockers reduces the probability of lethal arrhythmias after MI. 27 Because reductions in Kv currents have been linked to arrhythmogenesis, we investigated whether an increase in ␤AR stimulation leads to the reduction in I to , I Kslow1 , and I Kslow2 observed post-MI. A testable prediction of this hypothesis is that ␤AR blockers should minimize, or even prevent, the changes in I to , I Kslow1 , and I Kslow2 observed post-MI. Thus, the effects of the ␤AR blocker, metoprolol, on Kv currents after MI were investigated (Figure 3) .
For these experiments, mice were given metoprolol beginning 24 hours before infarction (BB-MI). Control (noninfarcted; BB) animals received metoprolol for the same period of time. Metoprolol treatment prevented the decrease in I tran and I sust amplitudes (PϾ0.05) observed post-MI ( Figure 3A and 3B). At ϩ40 mV, the amplitudes of I tran in BB and BB-MI cells were 49.37Ϯ3.34 pA/pF (nϭ23) and 47.78Ϯ2.3 pA/pF (nϭ25), respectively. Accordingly, I to , I Kslow1 , and I Kslow2 were similar in BB-MI and control cells ( Figure 3C through 3E) . Consistent with this, we found, using real-time PCR and Western blot analysis, that metoprolol prevented the reductions in Kv1.5, Kv2.1, Kv4.2, and Kv4.3 mRNA (nϭ21 hearts, PϾ0.05) and protein (nϭ6 hearts, PϾ0.05) observed in the ventricles post-MI ( Figure 3F and 3G) . post-MI via the activation of calcineurin/NFAT signaling. Indeed, analysis of the Kv1.5, Kv2.1, Kv4.2, and Kv4.3 genes revealed multiple putative NFAT binding elements (GGAAA) in the 5Ј untranslated region of these genes (see online data supplement). Thus, we tested the hypothesis that increased ␤AR stimulation activates NFAT post-MI and thereby reduces the expression of Kv1.5, Kv2.1, Kv4.2, and Kv4.3. These experiments involved a transgenic NFAT reporter mouse (NFAT-luc), in which luciferase expression is controlled by multiple NFAT binding sites. 28 We found that 48 hours after MI, luciferase activity in ventricular myocytes from areas remote to the MI was nearly 4-fold higher than in cells from the same region of noninfarcted hearts (NFAT-luc littermates) (control of 2.7Ϯ0.2 versus MI of 10.9Ϯ2.3 AU; n Ͼ100 cells from each of 3 hearts; PϽ0.05; Figure 4A ). Interestingly, this increase in NFAT activity after MI was prevented by metoprolol treatment (BB-MIϭ2.3Ϯ0.3 AU; n Ͼ100 cells from each of 3 hearts; PϾ0.05). Metoprolol did not alter NFAT activity in noninfarcted myocytes (BBϭ2.7Ϯ0.2 AU; n Ͼ100 cells from 3 hearts; PϽ0.05). These data suggest that activation of ␤ARs post-MI leads to the activation of NFAT in mouse ventricular myocytes.
Activation of NFAT After MI
CsA Prevents I to and I sust Reductions After MI
NFAT is activated by the Ca 2ϩ -sensitive phosphatase calcineurin. 13 Thus, we investigated whether activation of calcineurin was necessary to mediate the changes in I to , I Kslow1 , and I Kslow2 observed post-MI. To do this, Kv currents were recorded from cells dissociated from control (noninfarcted) and infarcted hearts from animals that had been administered a dose of CsA (25 mg/kg per day) shown, in vivo, to inhibit calcineurin activity in the heart. 15 CsA treatment began 48 hours before infarction and continued until hearts were harvested. Noninfarcted mice were treated with a similar regimen. Figure 4B through 4F shows the current-voltage relationships of Kv currents from control (noninfarcted, CsA-treated mice; nϭ21), untreated MI (nϭ26), and cells dissociated from infarcted hearts treated with CsA (MI-CsA; nϭ18). CsA prevented the reduction of the amplitudes of I tran and I sust (PϾ0.05; Figure 4B and 4C) after MI. Like metoprolol, CsA also prevented the decreases in I to , I Kslow1 , and I Kslow2 observed post-MI ( Figure 4D through 4F) . FK506, another calcineurin inhibitor, also prevented the decrease in Kv currents after MI (nϭ7, PϽ0.05; data not shown). These data suggest that calcineurin plays a central role in mediating the changes in I to , I Kslow1 , and I Kslow2 observed post-MI.
NFATc3 Mediates the Reductions in I to , I Kslow1 , and I Kslow2 Observed After MI
To further examine the role of NFATc3 in mediating MIinduced reductions in I to , I kslow1 , and I kslow2 , we performed experiments similar to those described above in NFATc3 knockout (NFATc3-KO) mice. Figure 5A shows representative Kv currents from ventricular myocytes dissociated from NFATc3-KO, infarcted NFATc3-KO (NFATc3-KO-MI), and infarcted wild-type (WT-MI) hearts. If activation of NFATc3 is necessary for the reduction in I to , I Kslow1 , and I Kslow2 observed post-MI, then there should be no reduction in these currents after MI in ventricular myocytes from NFATc3-KO mice. Supporting this hypothesis, Figure 5B through 5F show that although MI decreased I tran , I sust , I Kslow1 , I Kslow2 , and I to in WT cells (WT-MI; nϭ26), the amplitudes of these currents were similar (PϾ0.05) in NFATc3-KO (nϭ26) and NFATc3-KO-MI cells (nϭ14). Consistent with these data, Kv1.5, Kv2.1, Kv4.2, and Kv4.3 mRNA (nϭ20 hearts) and protein (nϭ6 hearts) did not decrease (PϾ0.05) after MI in NFATc3-KO ventricles ( Figure 5G and 5H) . These data suggest that NFATc3 plays an obligatory role in the reductions of I to , I Kslow1 , and I Kslow2 observed 48 hours post-MI. Interestingly, a comparison of Kv currents from WT and NFATc3-KO cells revealed that I to , but not I Kslow1 or I Kslow2 , was increased in NFATc3-KO cells, thus suggesting a degree of basal regulation of I to by NFATc3 (see online data supplement).
Chronic ␤AR Stimulation and a Constitutively Active NFATc3 Mimic the Effects of MI on I tran and I sust
To test if activation of NFATc3 was sufficient to account for the changes in I tran and I sust observed post-MI, we infected ventricular myocytes from uninfarcted WT mice with an adenoviral vector expressing a constitutively active EGFPtagged NFATc3 mutant (⌬NFATc3; Figure 6 ). Control cells were infected with an adenoviral vector expressing EGFP only. As expected, cells expressing activated NFATc3 showed high levels of fluorescence in their nuclei ( Figure  6A ). The rate of inactivation of the composite Kv currents at ϩ40 mV was similar in control ( fast ϭ43.1Ϯ8.4 ms, slow ϭ 623.8Ϯ107.9 ms, nϭ8) and ⌬NFATc3 cells ( fast ϭ44.7Ϯ5.8 ms, slow ϭ519.5Ϯ67.5 ms; nϭ8, PϾ0.05). However, expression of ⌬NFATc3 reduced (PϽ0.05) the amplitudes of I tran and I sust at most voltages examined. Note that cells cultured for 48 hours in the presence of the ␤-adrenergic agonist isoproterenol (ISO; 10 nmol/L) had I tran and I sust that were smaller than those from cells cultured for the same amount of time, but in the absence of ISO. Interestingly, ISO reduced I tran and I sust to the same extent as ⌬NFATc3 (nϭ6; PϾ0.05). These findings suggest that activation of NFATc3 and of ␤ARs reduce the amplitude of Kv currents in mouse ventricular myocytes.
Discussion
In this study, we provide the first direct demonstration that activation of NFATc3 is essential in the pathway leading to decreased Kv currents post-MI. Our data suggest that increased ␤-adrenergic signaling plays a pivotal role in the activation of NFATc3 after MI. We propose that activation of NFATc3 after MI downregulates Kv1.5, Kv2.1, Kv4.2, and Kv4.3 gene expression, thereby decreasing the amplitudes of I to , I Kslow1 , and I Kslow2 in mouse ventricular myocytes. The implications of these findings are discussed below.
AP and [Ca 2؉ ] i After MI
We found that decreased I to , I Kslow1 , and I Kslow2 accompanied AP prolongation post-MI. This is consistent with recent studies suggesting that I to , I Kslow1 , and I Kslow2 are responsible for the repolarization of the mouse ventricle. 22, 23 AP prolongation increases Ca 2ϩ influx via L-type Ca 2ϩ channels, SR Ca 2ϩ load, and SR Ca 2ϩ release during excitation-contraction coupling. 29 A similar mechanism may underlie the larger [Ca 2ϩ ] i transient observed here 48 hours post-MI. However, it is intriguing to speculate that increased ␤AR signaling 9 could also contribute to enhanced [Ca 2ϩ ] i early after MI. Changes in the maximal rate of depolarization and peak of the AP of control and MI cells were not observed, indicating that the Na ϩ current (I Na ) was not changed 48 hours post-MI. 5 In support of this, we found that I Na was similar in control and MI cells (Santana, Rossow, Minami, and Murry, unpublished data). Note, however, that changes in I Na have been observed 5 days post-MI. 6 Thus, decreased Kv currents appear to represent an earlier event in the progression of AP changes post-MI.
NFATc3 and Kv Expression in Ventricular Myocytes
The data suggesting that NFATc3 is an essential component of the signaling pathway mediating the changes in I to , I Kslow1 , and I Kslow2 after MI are compelling. First, we found that NFAT activity increased nearly 4-fold post-MI. This finding is consistent with a recent study showing NFATc3 hypophosphorylation 4 weeks post-MI. 16 Second, prevention of NFATc3 activation by pharmacological (metoprolol and presumably by CsA and FK506) or genetic (NFATc3-KO mice) interventions prevented the decreases in I to , I Kslow1 , and I Kslow2 observed after MI. Third, expression of an activated form of NFATc3 mimics the actions of MI and chronic ␤AR stimulation on Kv currents in mouse ventricular myocytes.
Our functional, mRNA and protein data suggest that reduced expression of Kv1.5, Kv2.1, Kv4.2, and Kv4.3 transcripts and proteins is the likely mechanism underlying the decreases in I to , I Kslow1 , and I Kslow2 post-MI. We found multiple-consensus NFAT-binding elements within the 5Ј untranslated region of the Kv1.5, Kv2.1, Kv4.2, and Kv4.3 genes. Thus, binding of NFATc3 to these genes could possibly alter their expression. This view is supported by a recent study showing that NFATc3 can downregulate the transcription of CD154, CDK4, IL-4, and IL-5 genes. 30 NFATc3 can therefore have a dual role as inducer or repressor of gene transcription.
An intriguing finding in this study is that activation of NFATc3 after MI downregulated I to and I Kslow1 to a larger extent than I Kslow2 . The molecular mechanisms underlying this difference are unclear, however. We did not detect a significant difference in the relative decrease of Kv4.3, Kv4.2, Kv2.1, and Kv1.5 mRNA and protein post-MI. The difference in the magnitude of the decrease in currents and Kv proteins post-MI could reflect changes in the expression of accessory subunits (eg, KChIPs, KChAPs, Kv␤s), trafficking and/or posttranslational processing of these channels. This is important because there are pronounced differences in the amplitude and kinetics of I to within different regions of the mouse heart. 23, 31 Indeed, the I to s reported here have a relatively large amplitude and are fully inactivated by Ϸ200 ms, which suggest that they likely represent the fast I to described in cells from the ventricular epicardium 31 and in some cells from the septum. 23 I Kslow1 is also differentially expressed within the mouse ventricle. Interestingly, Xu et al 23 found that I Kslow1 was larger in cells with larger fast I to . Future experiments should examine a possible role for NFATc3 in maintaining the regional heterogeneity of I to and I Kslow1 in the heart.
Ca
2؉ Signaling and NFATc3 Activity in the Heart
In a recent study by Sah et al, 32 overexpression of a truncated form of Kv4.2 decreased I to and prolonged the AP of ventricular myocytes of transgenic mice. They found that AP prolongation was associated with increased [Ca 2ϩ ] i and also with activation of calcineurin. These experiments suggested that calcineurin is downstream of changes in Kv currents. However, we overexpressed a constitutively active NFATc3 
Comparison With Other Studies
Our hypothesis that ␤ARs and NFATc3 play a central role in the downregulation of I to , I Kslow1 , and I Kslow2 post-MI is supported by recent work. Zhang et al 33 suggested that chronic activation of ␤ARs reduce the amplitude of delayed rectifier K ϩ currents in cultured guinea pig ventricular myocytes. Furthermore, it was reported that mice overexpressing calcineurin show early downregulation of Kv2.1 and Kv1.5 protein levels. 34 Hearts overexpressing calcineurin also had lower Kv4.2 protein expression than controls, but only after the development of heart failure. 34 A recent study by Deng et al 15 used calcineurin inhibition by CsA as a tool to evaluate the role of this phosphatase in mediating the changes in Kv currents observed in the rat post-MI. Consistent with our results and those of Petrashevskaya et al, 34 they found that CsA administration inhibited calcineurin and prevented the reductions in Kv4.2 and Kv2.1 expression observed post-MI. These findings support the hypothesis that activation of NFATc3 by calcineurin could underlie electrical remodeling of the heart after injury.
In addition to inducing Kv channel downregulation, MI causes hypertrophy. Two recent studies suggested that prevention of calcineurin activation using CsA 15 or by overexpressing the inhibitory calcineurin-interacting protein-1 16 decreased ventricular hypertrophy by up to 40% after MI. By comparison, our data indicate that preventing NFATc3 activation by pharmacological or genetic means completely prevents Kv current remodeling post-MI. Given that calcineurin/NFAT inhibition only partially blocks hypertrophy, whereas Kv downregulation is completely abrogated, we speculate that there may be less redundancy in the pathways leading to Kv downregulation.
Summary
Our results indicate that ␤ARs, calcineurin, and NFATc3 are part of a signaling pathway that reduces Kv currents post-MI. We propose that calcineurin reduces these currents by decreasing the expression of Kv1.5, Kv2.1, Kv4.2, and Kv4.3 channels via the activation of NFATc3. These findings provide a mechanistic model for the therapeutic use of ␤-blockers to reduce arrhythmogenic changes in Kv currents after MI. 
